It’s Not What You Call It that Matters; it’s Tracking Global Social Impact that Does
According to a recent survey conducted with ESG professionals, a staggering 90% of respondents believe that strong reporting and data management can…
Given the recent 303 Creative LLC v. Elenis Supreme Court decision in favor of “discrimination in the name of expression,”…
Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive…
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More